单位:[1]Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China华中科技大学同济医学院附属同济医院血液内科
Aberrant methylation of tumour suppressor genes is associated with the progression to a blast crisis in chronic myeloid leukaemia (CIVIL). Methyl-CpG-binding domain protein 2 (MBD2) has been studied as a "reader" of DNA methylation in many cancers, but its role in CIVIL is unclear. We constructed cell models of a homozygous deletion mutation of MBD2 using gene-editing technology in K562 cells and BV173 cells. Here, we demonstrated that the deletion of MBD2 inhibited cell proliferation capacity in vitro. MBD2 deletion also significantly inhibited K562 cell proliferation in a xenograft tumour model in vivo. Additionally, the JAK2/STAT3 signalling pathway, which is abnormally active in CIVIL, was inhibited by MBD2 deletion, and MBD2 deletion could up-regulate the expression of SHP1. In conclusion, our findings suggest that MBD2 is a candidate therapeutic strategy for the CIVIL blast phase.
基金:
Key Program of the National
Natural Science Foundation of China (JF Zhou, no. 81630006) and the
General Program of NNSF of China (JF Zhou, no. 81570196)., the Youth
Science Fund Project of NNSF of China (K Zhou, no. 81400122).
第一作者单位:[1]Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
通讯作者:
通讯机构:[1]Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China[*1]Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Road 1095#, Wuhan, Hubei, China, 430030.
推荐引用方式(GB/T 7714):
Ling Cheng,Ying Tang,Xing Chen,et al.Deletion of MBD2 inhibits proliferation of chronic myeloid leukaemia blast phase cells[J].Cancer biology & therapy.2018,19(8):676-686.doi:10.1080/15384047.2018.1450113.